Oxford Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-28,435
| Closed | -$80K | – | 1680 |
|
2019
Q4 | $80K | Sell |
28,435
-1,871
| -6% | -$5.26K | ﹤0.01% | 1638 |
|
2019
Q3 | $161K | Sell |
30,306
-2,176
| -7% | -$11.6K | ﹤0.01% | 1595 |
|
2019
Q2 | $312K | Buy |
32,482
+5,239
| +19% | +$50.3K | 0.01% | 1433 |
|
2019
Q1 | $730K | Sell |
27,243
-1,990
| -7% | -$53.3K | 0.02% | 1069 |
|
2018
Q4 | $661K | Buy |
29,233
+21,474
| +277% | +$486K | 0.02% | 1072 |
|
2018
Q3 | $433K | Buy |
+7,759
| New | +$433K | 0.01% | 1359 |
|
2017
Q2 | – | Sell |
-2,018
| Closed | -$371K | – | 1786 |
|
2017
Q1 | $371K | Buy |
2,018
+903
| +81% | +$166K | 0.01% | 1143 |
|
2016
Q4 | $90K | Buy |
+1,115
| New | +$90K | ﹤0.01% | 734 |
|
2016
Q1 | – | Sell |
-4,133
| Closed | -$836K | – | 952 |
|
2015
Q4 | $836K | Buy |
+4,133
| New | +$836K | 0.02% | 577 |
|